Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Matthew R. Sydes"'
Autor:
Ann Marie Swart, Patrick Royston, Michael A. Bookman, Ruth E Langley, Nicholas D. James, Mahesh K. B. Parmar, Elizabeth Eisenhauer, Matthew R. Sydes, Friederike Maria-Sophie Barthel, Wendi Qian, Mark F. Brady, Richard Kaplan
Publikováno v:
JNCI Journal of the National Cancer Institute
Despite both the increase in basic biologic knowledge and the fact that many new agents have reached various stages of development during the last 10 years, the number of new treatments that have been approved for patients has not increased as expect
Autor:
Matthew R. Sydes, Muhammad A. Memon, Antonie H. M. Taminiau, M. Nooij, S Weeden, Anne Kirkpatrick, Martine Van Glabbeke, Robert J. Grimer, Pancras C.W. Hogendoorn, Alan W. Craft, Ian Lewis, Jeremy Whelan, B. M. Uscinska, Esther Hauben
Publikováno v:
Journal of the National Cancer Institute. 99(2)
Background Previous randomized controlled trials that used the two-drug chemotherapy regimen of cisplatin and doxorubicin as the conventional arm showed no evidence of benefit from an increase in the number of agents or the length of treatment. It wa
Autor:
P. M. Thompson, Mahesh K. B. Parmar, Anne C. R. Robinson, Malcolm David Mason, David P. Dearnaley, Mark Stott, Sharon L. Naylor, Christopher S. Powell, Matthew R. Sydes, Leslie E. Moffat
Publikováno v:
Journal of the National Cancer Institute. 95(17)
Background: The most frequent site of metastases from prostate cancer is bone. Bisphosphonates reduce excessive bone turnover while preserving bone structure and mineralization in patients with other tumor types. We conducted a double-blind, placebo-